Outsourcing STREAM

1. Regulatory And Biosafety Testing Expertise 3/31/2026

   Advancing biologics requires confidence in safety, quality, and compliance. Learn how integrated analytical and biosafety testing, backed by decades of expertise, helps reduce risk.

2. Building Resilience In Biomanufacturing Operations 2/5/2026

   In this segment from the Bioprocess Online Live event, “Protecting Bioprocessing Operations and Supply Chains In A Turbulent Economy,” panelists share their thoughts on what it means to be resilient and how organizations can embody resilience in their biomanufacturing, which in part requires agility and preparation for the worst-case scenario. The panel was in agreement that earlier-phase companies have the highest opportunity to bake resilience into their operations.

3. Level Up With Product Characterization 3/12/2021

   In the race to bring a new biotherapeutic to market, unexpected obstacles can slow you down or even knock you back a few steps. But with the right information at the right time, and an experienced partner to provide scientific, regulatory, and bioprocessing guidance and support, you can find a smoother, faster path to the finish line.

4. Increasing The Reach Of Cell And Gene Therapies 4/29/2021

   The cell and gene therapy industry is rapidly evolving from the perspective of “can we commercialize this class of therapeutics?” to “how do we reach patients who need these therapies?”. However, the promise of these biologics can only be realized if the industry approaches manufacturing parity with monoclonal antibodies. A mixture of innovation and brute-force streamlining is needed to create viable cell and gene therapy templates. In this video, we discuss how upstream process optimization is ripe for innovative approaches.

5. MilliporeSigma Capacity Update October 2025: ADC 7/28/2025

   MilliporeSigma and Simtra's streamlined collaboration encompasses every stage, including bioconjugation, linker and payload supplies, formulation development, and final fill/finish of drug substance.

6. Discovering A Unique Multimillion Euro Nanotechnology Facility 10/25/2024

   Dr. David Rowe, Head of Manufacturing at Nanoform, provides an overview of Nanoform's manufacturing capabilities and introduces a new, state-of-the-art nanotechnology facility.

7. The Journey To Safety Through Viral Clearance 12/1/2022

   Discover a simple yet powerful solution for getting viral clearance studies done safely, thoroughly, efficiently, and on your timelines. Learn how to free your teams and trust your project.

8. How MilliporeSigma Promotes Quality And Risk Reduction 10/20/2021

   Learn how MilliporeSigma’s new facility was built with quality and risk reduction at the top of mind and its experts have the experience to support large-scale programs through commercialization.

9. MilliporeSigma Large Scale Capabilities Tour 10/20/2021

   A detailed look at MilliporeSigma’s new BioReliance® viral vector manufacturing facility and how we have employed the latest innovations and quality systems to deliver best-in-class gene therapy services.

10. Take A Virtual Tour Of Our Cell Line Development Centre Of Excellence 9/8/2025

    Explore the advanced capabilities of our Cell Line Development Center in Ulm, Germany. From expert teams to streamlined processes, discover how we support biopharma innovation.